5Y Historicals para AbbVie Inc (4AB)

Finanzas históricas a 5 años

Precio

190,04 EUR


Key Metrics	Latest
Total Revenue	56,334 B
Adjusted EBITDA	26,718 B
EBITDA Margin	47,4%
Net Profit Margin	24,3%
Total Assets	135,2 B
Total Debt	68,019 B

5Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months	Dec-23	Dec-24

Revenue	45,804.00	56,197.00	58,054.00	54,318.00	56,334.00	56,334.00	54,318.00	56,334.00
% Growth		0.23	0.03	(0.06)	0.04			0.04

Adjusted EBITDA	21,148.00	28,280.00	28,695.00	26,358.00	26,718.00	26,718.00	25,862.00	25,535.00
% Margin	0.46	0.50	0.49	0.49	0.47	0.47	0.48	0.45

Adjusted EBIT	14,677.00	19,759.00	20,228.00	17,660.00	18,332.00	18,332.00	17,164.00	17,149.00
% Margin	0.32	0.35	0.35	0.33	0.33	0.33	0.32	0.30

Adjusted Net Income	11,312.34	14,797.60	15,323.74	12,102.80	13,688.44	13,688.44	11,735.76	12,813.02
% Margin	0.25	0.26	0.26	0.22	0.24	0.24	0.22	0.23

Adjusted Basic EPS	6.79	8.36	8.65	6.85	7.74	7.74	6.64	7.24

Cálculos de apoyo

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
						Original
USD	Fiscal Year Ending					Latest	Year-to-date Ending
(in millions)	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24	Dec-23	Dec-24
	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM	YTD-1	YTD

Revenue	45,804	56,197	58,054	54,318	56,334	56,334	54,318	56,334
% Growth	NA	22.7%	3.3%	-6.4%	3.7%			3.7%

Cost of Revenue	(15,257)	(17,314)	(16,527)	(16,726)	(16,689)	(16,689)	(16,726)	(16,689)
Gross Profit	30,547	38,883	41,527	37,592	39,645	39,645	37,592	39,645
% Revenue	66.7%	69.2%	71.5%	69.2%	70.4%	70.4%	69.2%	70.4%

Research and Development	(7,755)	(8,046)	(7,207)	(8,453)	(15,548)	(15,548)	(8,453)	(15,548)
Selling and Marketing	(1,800)	(2,100)	(2,000)	(2,200)	(2,100)	(2,100)	(2,200)	(2,100)
General and Admin	(8,067)	(9,772)	(12,584)	(10,704)	(11,089)	(11,089)	(10,704)	(11,089)
Other Inc / (Exp)	(7,247)	(3,592)	(4,215)	(8,301)	(5,032)	(5,032)	(8,301)	(5,032)
Total Operating Exp	(24,869)	(23,510)	(26,006)	(29,658)	(33,769)	(33,769)	(29,658)	(33,769)

Operating Income	5,678	15,373	15,521	7,934	5,876	5,876	7,934	5,876
% Revenue	12.4%	27.4%	26.7%	14.6%	10.4%	10.4%	14.6%	10.4%

Interest Expense	(2,280)	(2,384)	(2,044)	(1,684)	(2,160)	(2,160)	(1,684)	(2,160)
Pre-tax Income	3,398	12,989	13,477	6,250	3,716	3,716	6,250	3,716
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0
Provision for Taxes	1,224	(1,440)	(1,632)	(1,377)	570	570	(1,377)	570
Net Income to Company	4,622	11,549	11,845	4,873	4,286	4,286	4,873	4,286
% Margin	10.1%	20.6%	20.4%	9.0%	7.6%	7.6%	9.0%	7.6%

Minority Interest in Earnings	(6)	(7)	(9)	(10)	(8)	(8)	(10)	(8)
Net Income to Stockholders	4,616	11,542	11,836	4,863	4,278	4,278	4,863	4,278

Preferred Dividends	0	0	0	0	0	0	0	0
Other Adj.	(60)	(74)	(54)	(43)	(40)	(40)	(43)	(40)

Net Income to Common	4,556	11,468	11,782	4,820	4,238	4,238	4,820	4,238
% Margin	9.9%	20.4%	20.3%	8.9%	7.5%	7.5%	8.9%	7.5%

As Reported
Basic EPS (Continuing Ops)	2.73	6.48	6.65	2.73	2.40	2.40	2.73	2.40
Diluted EPS (Continuing Ops)	2.72	6.45	6.63	2.72	2.39	2.39	2.72	2.39

WA Basic Shares Out.	1,667.00	1,770.00	1,771.00	1,768.00	1,769.00	1,769.00	1,768.00	1,769.00
WA Diluted Shares Out.	1,673.00	1,777.00	1,778.00	1,773.00	1,773.00	1,773.00	1,773.00	1,773.00

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	3,398	12,989	13,477	6,250	3,716	3,716	6,250	3,716
Addback: Net Interest Expense	2,280	2,384	2,044	1,684	2,160	2,160	1,684	2,160
Addback: Other Non Operating Expenses, Total	(42)	(4)	6	(44)	(250)	(250)	(44)	(250)
Addback: Depreciation & Amortization	6,471	8,521	8,467	8,698	8,386	8,386	8,698	8,386
Addback: Restructuring Charges	0	0	0	0	0	0	0	0
Addback: Merger / Acquisition Expenses	1,912	587	539	119	792	792	119	792
Addback: Goodwill Impairment	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Assets	0	0	(172)	0	0	0	0	0
Addback: Asset Writedown	0	0	876	4,230	4,476	4,476	4,230	4,476
Addback: In Process R&D Expenses	1,376	1,124	697	778	2,757	2,757	282	1,574
Addback: Insurance Settlements	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	(485)	910	910	(485)	910
Addback: Other Unusual Items	5,753	2,679	2,761	5,128	3,771	3,771	5,128	3,771
Adjusted EBITDA	21,148	28,280	28,695	26,358	26,718	26,718	25,862	25,535
% Margin	46.2%	50.3%	49.4%	48.5%	47.4%	47.4%	47.6%	45.3%

Adjusted EBIT	14,677	19,759	20,228	17,660	18,332	18,332	17,164	17,149
% Margin	32.0%	35.2%	34.8%	32.5%	32.5%	32.5%	31.6%	30.4%

Adjusted Net Income Reconciliation
Net Income to Company	4,622	11,549	11,845	4,873	4,286	4,286	4,873	4,286
Addback: Unusual Items	9,041	4,390	4,701	9,770	12,706	12,706	9,274	11,523
Less: Tax Benefit of Unusual Items (26%)	(2,351)	(1,141)	(1,222)	(2,540)	(3,304)	(3,304)	(2,411)	(2,996)
Adjusted Net Income	11,312	14,798	15,324	12,103	13,688	13,688	11,736	12,813
% Margin	24.7%	26.3%	26.4%	22.3%	24.3%	24.3%	21.6%	22.7%

Error de carga

Finanzas históricas a 5 años